SCHEMBL7189516

SCHEMBL7189516

CC(C)(C)Oc1cc(OC(C)(C)C)c(C(C)(C)C)cc1/C=C/C(=O)c1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 8/20 0.50
CTSL P07711 1/20 0.50
CTSB P07858 1/20 0.50
ABCG2 Q9UNQ0 3/20 0.49
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
KRAS P01116 1/20 0.46
DPP4 P27487 2/20 0.44
IDH1 O75874 1/20 0.44
ABCB1 P08183 1/20 0.44
UGT1A1 P22309 1/20 0.44
ABCC1 P33527 1/20 0.44
PRMT6 Q96LA8 1/20 0.44
BCHE P06276 1/20 0.44
CYP1B1 Q16678 2/20 0.44
CYP1A1 P04798 1/20 0.44
CAPN1 P07384 1/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189520 1.00 PTPN1 (0.50) PTPN1CTSLCTSBABCG2CA1
SCHEMBL7796241 0.89 PTPN1 (0.60) PTPN1CTSLCTSBABCG2DPP4
SCHEMBL7796243 0.89 PTPN1 (0.60) PTPN1CTSLCTSBABCG2DPP4
SCHEMBL7187781 0.89 PTPN1 (0.63) PTPN1CTSLCTSBABCG2CA1
SCHEMBL7187778 0.89 PTPN1 (0.63) PTPN1CTSLCTSBABCG2CA1
SCHEMBL9113945 0.87 PTPN1 (0.64) PTPN1ABCG2DPP4KDM4ELMNA
SCHEMBL7185074 0.86 ABCG2 (0.64) PTPN1CTSLCTSBABCG2CA1
SCHEMBL7186038 0.86 CTSL (0.51) PTPN1CTSLCTSBABCG2CA1
SCHEMBL7185085 0.86 ABCG2 (0.64) PTPN1CTSLCTSBABCG2CA1
SCHEMBL7186034 0.86 CTSL (0.51) PTPN1CTSLCTSBABCG2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed